Overview
Rat angiogenesis is a cornerstone of preclinical research, providing insights into vascular growth mechanisms relevant to human pathologies. Rodent models, particularly rats, are favored for their physiological similarity to humans and adaptability to genetic manipulation. Studies often focus on conditions like ischemic diseases, tumor progression, and diabetic retinopathy. Researchers utilize techniques such as the aortic ring assay and Matrigel plug assays to quantify vessel formation. These models help evaluate pro-angiogenic or anti-angiogenic compounds, bridging laboratory findings to clinical applications. The field has advanced with CRISPR-engineered rat strains, enabling targeted studies of specific molecular pathways.
Key Features
Rat angiogenesis models exhibit high reproducibility and scalability, making them ideal for high-throughput drug screening. Key metrics include microvessel density, branching patterns, and perfusion rates, often analyzed via immunohistochemistry or micro-CT imaging. Notably, rat models accommodate longitudinal studies due to their larger size compared to mice, allowing repeated sampling. However, strain-specific differences (e.g., Sprague-Dawley vs. Wistar) may influence outcomes, necessitating careful selection. Hypoxia-induced models are common for simulating ischemic conditions, while tumor xenografts assess cancer-related angiogenesis.
Application Areas
In oncology, rat angiogenesis models elucidate tumor vasculature dynamics, aiding anti-cancer drug development (e.g., VEGF inhibitors). Cardiovascular research employs these models to study collateral circulation post-myocardial infarction. Regenerative medicine benefits from assessing graft vascularization in tissue engineering. Additionally, age-related macular degeneration (AMD) studies use retinal angiogenesis models. The pharmaceutical industry relies on such preclinical data to prioritize candidate therapies before human trials, reducing attrition rates.
Precautions
Ethical compliance is mandatory, with protocols adhering to institutional animal care guidelines (e.g., NIH or AAALAC). Anesthesia and analgesia must be optimized to minimize distress during invasive procedures like surgical ischemia induction. Technical challenges include maintaining consistent hypoxia levels or ensuring Matrigel stability. Researchers should account for sex-based differences in angiogenic responses and standardize housing conditions to reduce variability. Data interpretation requires controls for inflammation-induced angiogenesis.
B2B Procurement Guide
Suppliers of rat angiogenesis models include Charles River Laboratories and Taconic Biosciences, offering specific pathogen-free (SPF) strains. Custom genetically modified rats are available from firms like Horizon Discovery, with lead times of 6–12 months. Reagents like growth factor-reduced Matrigel (Corning) are essential for assays; bulk purchases may reduce costs by 15–20%. For imaging equipment, consider PerkinElmer’s IVIS systems for in vivo tracking. Budget for ancillary costs (e.g., histology services at ~$100–$300 per sample).
Related Manufacturers
- 主营：大鼠血管生成素1ELISAKit、ELISA试剂盒、PCR试剂盒、科研试剂
- 主营：大鼠血管生成抑制因子、试剂盒、ELISA试剂盒、ELISA检测试剂盒
- 主营：ELISA试剂盒、PCR试剂盒、生化试剂盒、科研试剂
- 主营：科研试剂盒、酶免试剂盒、elisa试剂盒、血管生成素1ELISA试剂盒、细胞、生物试剂、进口ELISA试剂盒、PCR试剂盒、生化测试盒
- 主营：科研试剂盒、酶免试剂盒、elisa试剂盒、生化试剂盒、细胞、生物试剂、进口ELISA试剂盒、PCR试剂盒、生化测试盒
- 主营：试剂盒、乙酰化酶、巨噬细胞蛋白、细胞标记蛋白、人组织蛋白酶、相容性复合体、人转录中介因子、前列腺特异抗原、纤溶酶原激活剂、人转化生长因子、人组蛋白赖氨酸
- 主营：试剂盒、同源物、脂蛋白、合蛋白、粘液素、抑制素、亲环素、保护素、信号素、胞色素、脂肪酶、末端肽、磷脂酶、蛋白酶、变位酶、抑制剂、脱水酶、抑制物、凝蛋白、激活肽、连接酶、样激酶、解氨酶、恒温箱、利钠肽
- 主营：试剂盒、ELISA试剂盒、科研ELISA试剂盒、PCR试剂盒、生化试剂盒
- 主营：大鼠血管生成素2、Elisa试剂盒、检测试剂盒
- 主营：elisa试剂盒、人elisa试剂盒、小鼠elisa试剂盒、大鼠elisa试剂盒、植物elisa试剂盒、鱼elisa试剂盒、猪elisa试剂盒、牛elisa试剂盒、鸡elisa试剂盒、兔elisa试剂盒、犬elisa试剂盒
- 主营：elisa试剂盒、检测试剂盒、酶免试剂盒、通蔚生物试剂盒、elisakit
- 主营：ELISA检测试剂盒
- 主营：elisa试剂盒、pcr检测试剂盒
- 主营：ELISA试剂盒、PCR试剂盒、科研试剂
- 主营：ELISA试剂盒、抗体